Leila Hosseini

10PUBLICATIONS
21CO-AUTHORS
Molecular targetsPsychopharmacologyComputational neuroscience (incl. mathematical neuroscience and theoretical neuroscience)Metabolic medicineTraditional Chinese medicine and treatments
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jun 19, 2026
Therapeutic potential of AdipoRon in cognitive, depressive, and anxiety disorders: a systematic review and meta-analysis.

|Nov 07, 2025
Cerebrolysin ameliorates ketamine-mediated anxiety and cognitive impairments via modulation of mitochondrial function and CREB/PGC-1α pathway.

Leila Hosseini, Nasrin Abolhasanpour, Fatemehsadat Seyedaghamiri

|Jul 16, 2025
Effects of cerebrolysin on behavioral changes and the tryptophan-kynurenine pathway in the prefrontal cortex of male mice in the ketamine model of schizophrenia.

Vida Mafikandi, Leila Hosseini, Fatemehsadat Seyedaghamiri

|Mar 03, 2025
A systematic review of the therapeutic potential of nicotinamide adenine dinucleotide precursors for cognitive diseases in preclinical rodent models.

Musaab Abdulrazzaq Qader, Leila Hosseini, Nasrin Abolhasanpour

|Sep 27, 2024
Nasal administration of mitochondria relieves depressive- and anxiety-like behaviors in male mice exposed to restraint stress through the suppression ROS/NLRP3/caspase-1/IL-1β signaling pathway.

Vida Mafikandi, Fatemehsadat Seyedaghamiri, Naeimeh Hosseinzadeh

|Aug 17, 2024
Klotho: molecular mechanisms and emerging therapeutics in central nervous system diseases.

Leila Hosseini, Soraya Babaie, Parviz Shahabi

Pageof 2

Frequent Collaborators

2 joint publications

Ali Fakhari

1 joint publications

Hanieh Salehi-Pourmehr

1 joint publications

Amirreza Naseri

1 joint publications

Leila Roshangar